Zurueck zur Suche

Reporte zur Charge AU1075A

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

8Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
FL 2 KY 1 MD 1 VA 1

VAERS 2699315

SEQIRUS, INC. · INFLUENZA (SEASONAL) (AFLURIA QUADRIVALENT) · Charge AU1075A

schwer
Staat
-
Alter
23,0
Geschlecht
M
Eingang
20.10.2023
Impfdatum
20.10.2023
Beginn
20.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blood pressure decreased Confusional state Disorientation Dizziness Hyperhidrosis Loss of consciousness Malaise Pallor

Symptomtext

At 0902 am, pt received Afluria in his left deltoid and typhoid in his right. Very shortly after that the patient c/o "not feeling well". Pt lost consciousness for no more than 30seconds and came back very confused and disoriented. At 0904, rapid response was called. Pt was placed in Trendelenburg position and was assessed to be very pale and diaphoretic. BP dropped to 78/88 HR 45. Around 0905, pt was more oriented but stated that he still felt very light headed. Patient had not eaten food prior to the event. He denies any sickness or any issues with vaccines prior to this event. Pt drank a Gatorade and ate a nutrigrain bar. Repeat vitals at 108/54. Continued to monitor pt as he became more engaged and aroused. He slowly adjusted to standing without feelings of syncope and was discharge by medical doctor on call in stable condition.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Naproxen 375mg prn for pain
Allergien
none listed at the time of the reaction. Patient had negative screen for allergy.
Vorherige Impfungen
-

VAERS 2696409

SEQIRUS, INC. · INFLUENZA (SEASONAL) (AFLURIA QUADRIVALENT) · Charge AU1075A

schwer
Staat
FL
Alter
28,0
Geschlecht
M
Eingang
16.10.2023
Impfdatum
16.10.2023
Beginn
16.10.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Pallor Syncope Unresponsive to stimuli

Symptomtext

* Final Report * Patient presented to influenza mass vaccination site at 0829. Negative Screening - okay to give vaccine. 0830: Vaccine Administered. Patient sat down in chair due to 'feeling dizzy' 0831: Patient Syncopal Episode. RN Alerted. Provider entered room, proceeded to assess patient. Code was initiated due to no patient response. Patient had pulse and respirations Within 30 seconds, patient was responsive to verbal stimuli. Code Cancelled. No vital signs machine on deck, runner sent. Patient AOx4 - stated no SOB, no trouble breathing. Patient has pale lips. 0836: Nurse remains at chairside, Patient reported no shortness of breath. Reports feeling better. Patient states that he 'has a 50-50 chance to pass out after getting any vaccine.' Patient educated to let staff know this prior to getting another vaccine. 0839: Nurse leaves bedside. Calls report to Dr. Plan for vital signs as soon as the machine arrives and again 30 minutes post-vaccine. 0845: Vitals: 131/81, R 17, SpO2 99%, HR 76, T 98.5. 0910: Vitals: 127/76, R 16, SpO2 99%, HR 79, T 98.9 0915: Patient released back to workspace. ER precautions given.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
-
Allergien
No Known Allergies
Vorherige Impfungen
Patient reports that he 'has a 50:50 chance to pass out after a vaccine'. He states this has happened in the past numerous time

VAERS 2693609

SEQIRUS, INC. · INFLUENZA (SEASONAL) (AFLURIA QUADRIVALENT) · Charge AU1075a

schwer
Staat
KY
Alter
32,0
Geschlecht
M
Eingang
10.10.2023
Impfdatum
10.10.2023
Beginn
10.10.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Ataxia Disorientation Hyperventilation Hyporeflexia Postictal state Seizure like phenomena Tongue biting

Symptomtext

Patient with history of seizure activity presented with seizure-like activity approximately 5 hours after vaccination. Patient appeared disoriented and postictal following the episode. Episode lasted approximately 2 minutes. Patient was hyperventilating, and alert but not oriented during the postictal phase. Patient bit his tongue during the episode, but did not have significant bleeding. Patient was evaluated by EMS, and refused transport against medical advise. Neuro-exam by on-site medical provider revealed sluggish reflexes, and minor dystaxia. Patient was picked up from work by his wife, with instructions to follow up with previously established Neurology provider.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure like phenomena
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
History of Seizure Activity
Andere Medikamente
Cetirizine, Pseudoephedrine,
Allergien
Sulfa
Vorherige Impfungen
-

VAERS 2722771

SEQIRUS, INC. · INFLUENZA (SEASONAL) (AFLURIA QUADRIVALENT) · Charge au1075a

moderat
Staat
MD
Alter
38,0
Geschlecht
M
Eingang
11.12.2023
Impfdatum
08.11.2023
Beginn
01.11.2023
Tage bis Beginn
-
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injected limb mobility decreased Injection site pain X-ray

Symptomtext

Localized pain to the left upper arm at the vaccination site without edema or erythema, now with decreased range of motion.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
plain films pending referral to physical therapy
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NONE
Vorherige Impfungen
-

VAERS 2696247

SEQIRUS, INC. · INFLUENZA (SEASONAL) (AFLURIA QUADRIVALENT) · Charge AU1075A

moderat
Staat
-
Alter
30,0
Geschlecht
M
Eingang
24.11.2023
Impfdatum
15.10.2023
Beginn
15.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Hypoaesthesia Paraesthesia

Symptomtext

Numbness in his R foot that traveled up to his knee and R hand; Tingly in his R foot that traveled up to his knee and R hand; This spontaneous case was retrieved on 13-Nov-2023 from Vaccine Adverse Event Reporting System (VAERS) (reference number: 2696247-1), reported by other healthcare professional, and concerned a 30-year-old, male patient. The patient's medical history and concomitant medications were not reported. The patient had no known drug allergies. It was reported that on 15-Oct-2023 at 10:00 am, the patient was vaccinated with Fluad Quadrivalent (influenza vaccine inact sag 4v; dose: reported as 1, route of administration: intramuscular (IM), anatomical location: right arm (RA), and indication: not reported). The batch number reported was AU1075A. The reported batch number was identified by Seqirus to be linked to the suspect product Afluria Quadrivalent (Influenza vaccine inact split 4v) instead of the reported suspect product Fluad Quadrivalent. Based on the reported batch number, the suspect product was changed to Afluria Quadrivalent. On the same date, minutes after vaccination with Afluria Quadrivalent, the patient experienced mild tingling and numbness in his right foot. As reported, the patient ignored the symptoms until hours later when they didn't go away and travelled up to the knee and right hand. On the same date, the patient had a medical examination by provider, and showed no signs of anaphylactic shock. Neurological assessment: within defined limits (WDL) with exception of numbness and tingling in reported areas. The patient's vital signs were blood pressure (BP) 150/89, heart rate (HR) 102, temperature (T) 98.8 oral, oxygen saturation (O2) 96%, and respiratory rate (RR) 18. No units were provided. At the time of the initial reporting, the patient had not recovered from the events. The reporter did not provide a causality assessment. The case was assessed as non-serious. Company comment: On the same date, minutes after vaccination with Afluria Quadrivalent, the patient experienced mild tingling and numbness in his right foot. As reported, the patient ignored the symptoms until hours later when they didn't go away and travelled up to the knee and right hand. The patient's medical history and concomitant medications were not reported. Causal role of the suspect vaccine is assessed as possibly related, based on chronological plausibility.; Sender's Comments: On the same date, minutes after vaccination with Afluria Quadrivalent, the patient experienced mild tingling and numbness in his right foot. As reported, the patient ignored the symptoms until hours later when they didn't go away and travelled up to the knee and right hand. The patient's medical history and concomitant medications were not reported. Causal role of the suspect vaccine is assessed as possibly related, based on chronological plausibility.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
Test Date: 20231015; Test Name: BP; Result Unstructured Data: 150/89; Test Date: 20231015; Test Name: T; Result Unstructured Data: 98.8 oral; Test Date: 20231015; Test Name: HR; Result Unstructured Data: 102; Test Date: 20231015; Test Name: Neuro assessment; Result Unstructured Data: Within defined limits (WDL) with exception of numbness and tingling in reported areas.; Test Date: 20231015; Test Name: O2; Result Unstructured Data: 96%; Test Date: 20231015; Test Name: RR; Result Unstructured Data: 18; Test Date: 20231015; Test Name: Examination; Result Unstructured Data: No signs of anaphylactic shock
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: None
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2696247

SEQIRUS, INC. · INFLUENZA (SEASONAL) (FLUAD QUADRIVALENT) · Charge AU1075A

moderat
Staat
-
Alter
30,0
Geschlecht
M
Eingang
24.11.2023
Impfdatum
15.10.2023
Beginn
15.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Hypoaesthesia Paraesthesia

Symptomtext

Numbness in his R foot that traveled up to his knee and R hand; Tingly in his R foot that traveled up to his knee and R hand; This spontaneous case was retrieved on 13-Nov-2023 from Vaccine Adverse Event Reporting System (VAERS) (reference number: 2696247-1), reported by other healthcare professional, and concerned a 30-year-old, male patient. The patient's medical history and concomitant medications were not reported. The patient had no known drug allergies. It was reported that on 15-Oct-2023 at 10:00 am, the patient was vaccinated with Fluad Quadrivalent (influenza vaccine inact sag 4v; dose: reported as 1, route of administration: intramuscular (IM), anatomical location: right arm (RA), and indication: not reported). The batch number reported was AU1075A. The reported batch number was identified by Seqirus to be linked to the suspect product Afluria Quadrivalent (Influenza vaccine inact split 4v) instead of the reported suspect product Fluad Quadrivalent. Based on the reported batch number, the suspect product was changed to Afluria Quadrivalent. On the same date, minutes after vaccination with Afluria Quadrivalent, the patient experienced mild tingling and numbness in his right foot. As reported, the patient ignored the symptoms until hours later when they didn't go away and travelled up to the knee and right hand. On the same date, the patient had a medical examination by provider, and showed no signs of anaphylactic shock. Neurological assessment: within defined limits (WDL) with exception of numbness and tingling in reported areas. The patient's vital signs were blood pressure (BP) 150/89, heart rate (HR) 102, temperature (T) 98.8 oral, oxygen saturation (O2) 96%, and respiratory rate (RR) 18. No units were provided. At the time of the initial reporting, the patient had not recovered from the events. The reporter did not provide a causality assessment. The case was assessed as non-serious. Company comment: On the same date, minutes after vaccination with Afluria Quadrivalent, the patient experienced mild tingling and numbness in his right foot. As reported, the patient ignored the symptoms until hours later when they didn't go away and travelled up to the knee and right hand. The patient's medical history and concomitant medications were not reported. Causal role of the suspect vaccine is assessed as possibly related, based on chronological plausibility.; Sender's Comments: On the same date, minutes after vaccination with Afluria Quadrivalent, the patient experienced mild tingling and numbness in his right foot. As reported, the patient ignored the symptoms until hours later when they didn't go away and travelled up to the knee and right hand. The patient's medical history and concomitant medications were not reported. Causal role of the suspect vaccine is assessed as possibly related, based on chronological plausibility.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
Test Date: 20231015; Test Name: BP; Result Unstructured Data: 150/89; Test Date: 20231015; Test Name: T; Result Unstructured Data: 98.8 oral; Test Date: 20231015; Test Name: HR; Result Unstructured Data: 102; Test Date: 20231015; Test Name: Neuro assessment; Result Unstructured Data: Within defined limits (WDL) with exception of numbness and tingling in reported areas.; Test Date: 20231015; Test Name: O2; Result Unstructured Data: 96%; Test Date: 20231015; Test Name: RR; Result Unstructured Data: 18; Test Date: 20231015; Test Name: Examination; Result Unstructured Data: No signs of anaphylactic shock
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: None
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2716855

SEQIRUS, INC. · INFLUENZA (SEASONAL) (AFLURIA QUADRIVALENT) · Charge AU1075A

mild
Staat
VA
Alter
42,0
Geschlecht
F
Eingang
22.11.2023
Impfdatum
07.11.2023
Beginn
07.11.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Injection site erythema Injection site mass Injection site warmth Limb discomfort Pain in extremity Peripheral swelling

Symptomtext

Experiencing right arm pain, swelling and discomfort to the right arm. She reported there is some warmth to the skin tissue surrounding the injection site, some redness that is radiating from the injection site, approximately five inches, and a lump around the injection site. Patient reported she presented to the local urgent care the next day since symptoms didn't resolve and self medicating with ibuprofen didn't resolve the pain or discomfort. She reported she was prescribed antibiotic, Benadryl, and an epinephrine pen. Caller is trying to determine if what she is experiencing is normal since she hasn't ever had these symptoms after receiving any vaccines in the past.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2698436

SEQIRUS, INC. · INFLUENZA (SEASONAL) (AFLURIA QUADRIVALENT) · Charge AU1075A

mild
Staat
FL
Alter
45,0
Geschlecht
M
Eingang
19.10.2023
Impfdatum
19.10.2023
Beginn
19.10.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Urticaria

Symptomtext

Patient received vaccine - Afluria at approximately 1200 PM. At 1330, member presented to mass vaccination site with complaints of Hives. Patient was assessed - and confirmed HIVES. Patient states back in 2007 he also had a reaction to the influenza vaccine - he states then it was worse with immediate anaphylaxis.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None Reported
Vorgeschichte
None
Andere Medikamente
Yes -
Allergien
Food - Pineapple
Vorherige Impfungen
2007- Anaphylaxis